An exploration of how targeted nanoparticles and artificial intelligence algorithms combine to locate prostate cancer earlier ...
Morning Overview on MSN
Study says AI can flag pancreatic cancer years before symptoms
Pancreatic cancer has one of the bleakest survival rates in oncology. Just 13% of patients are alive five years after ...
EarlyDiagnostics (EarlyDx) announced PNAS validation of its MethylScan™ platform for multi-disease detection from a single blood sample.
Prostate cancer remains one of the most common diseases among men, yet current screening methods often lead to unnecessary ...
Weinstein Imaging Associates joins as clinical site to collect breath samples to advance development of a breath test for ...
OpenAI has launched GPT-Rosalind, an AI model tailored for life sciences, alongside new research from UC San Diego on a machine learning tool that more accurately predicts Type 1 diabetes risk. These ...
Long-Term Survival and Biomarker Analysis Evaluating Neoadjuvant Plus Adjuvant Relatlimab (anti-LAG3) and Nivolumab (anti-PD1) in Patients With Resectable Melanoma Our study included a broad cohort of ...
A recent study published in Cell Reports Medicine has identified distinct microbial signatures within the oral cavity and gut ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results